Prognostic biomarkers in uveal melanoma: The status quo, recent advances and future directions

NJ Lamas, A Martel, S Nahon-Estève, S Goffinet… - Cancers, 2021 - mdpi.com
Simple Summary Although rare, uveal melanoma (UM) is the most common cancer that
develops inside adult eyes. The prognosis is poor, since 50% of patients will develop lethal …

Exudative retinal detachment

R Amer, H Nalcı, N Yalçındağ - Survey of ophthalmology, 2017 - Elsevier
Exudative retinal detachment develops when fluid collects in the subretinal space. The
subretinal space between the photoreceptors and the retinal pigment epithelium is the …

[PDF][PDF] The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings

D John, M Earle, SL Fine, BS Hawkins… - Arch …, 2001 - academia.edu
Objectives: To report initial mortality findings from the Collaborative Ocular Melanoma Study
(COMS) randomized clinical trial of iodine 125 brachytherapy vs enucleation for treatment of …

Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma

T Mäkitie, P Summanen… - … & visual science, 2001 - iovs.arvojournals.org
purpose. To investigate the hypothesis that tumor-infiltrating macrophages contribute to
prognosis of uveal melanoma and to study their association with tumor characteristics …

The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas

S Nag, JM Quivey, JD Earle, D Followill… - International Journal of …, 2003 - Elsevier
PURPOSE: This article presents the American Brachytherapy Society (ABS) guidelines for
the use of brachytherapy for patients with choroidal melanomas. METHODS: Members of the …

Prognostic factors in uveal melanoma

AD Singh, CL Shields, JA Shields - Melanoma research, 2001 - journals.lww.com
Uveal melanoma is the most common primary intraocular malignant tumour, with an annual
incidence of approximately six cases per million per year. Approximately 40% of patients …

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS report no. 18

Collaborative Ocular Melanoma Study … - Archives of …, 2001 - jamanetwork.com
Objectives To report initial mortality findings from the Collaborative Ocular Melanoma Study
(COMS) randomized clinical trial of iodine 125 brachytherapy vs enucleation for treatment of …

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report …

Collaborative Ocular Melanoma Study Group - American journal of …, 1998 - Elsevier
Purpose: To report initial mortality findings from the Collaborative Ocular Melanoma Study
(COMS) randomized clinical trial of pre-enucleation radiation of large choroidal melanoma …

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.

M Diener-West, JD Earle, SL Fine… - … (Chicago, Ill.: 1960), 2001 - europepmc.org
Objectives To describe characteristics of patients evaluated for the Collaborative Ocular
Melanoma Study (COMS) randomized clinical trial of iodine 125 brachytherapy for choroidal …

The pathology of ocular cancer

RC Eagle - Eye, 2013 - nature.com
Primary cancers of the eye are rare. These include uveal melanoma, a tumor that
preferentially affects the choroid of light-eyed, fair-skinned Europeans, and the pediatric …